Bovie Medical (BVX) Stock Price, News & Analysis

Company Overview

Bovie Medical Corporation was a medical device company that developed, manufactured and marketed electrosurgical products for hospitals, outpatient facilities and physician practices. Its product portfolio included electrosurgical generators, pencils, electrodes, grounding pads, accessories and smoke-evacuation systems used in surgical procedures.

The company also developed advanced energy technology based on its patented helium plasma platform. Its J-Plasma and related systems were designed to deliver controlled energy for cutting, coagulation and soft-tissue procedures, with applications across several surgical specialties. Bovie marketed products under its own brand and also supplied devices and components to original equipment manufacturers.

Bovie Medical sold its products in the United States and internationally through direct sales and distribution partners. In 2018, the company changed its name to Apyx Medical Corporation following the expansion of its plasma-based surgical technology business. The company is therefore primarily of historical interest under the Bovie Medical name; its former operations and products became part of Apyx Medical’s business.

Key Stats

• Today's Range: $6.35 to $6.71
• 50-Day Range: $6.48 to $6.48
• 52-Week Range: $2.28 to $7.70
• Volume: 129,500 shs
• Average Volume: 136,878 shs
• Market Capitalization: $215.14 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: NYSEAMERICAN
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: NYSEAMERICAN:BVX
• Previous Symbol: AMEX:BVX
• CIK: 719135
• Web: www.boviemedical.com
• Phone: (727) 384-2323
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 33,200,000
• Free Float: N/A
• Market Cap: $215.14 million
• Optionable: Not Optionable
• Beta: N/A